Neutrophilic and Pauci-immune Phenotypes in Severe Asthma

Immunology and Allergy Clinics of North America

Volumn 36, Issue 3, 2016, Pages 569-579

  Panettieri, Reynold A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Airway remodeling; Intrinsic asthma; Irreversible airway obstruction; Nonatopic asthma; Steroid insensitivity

Indexed keywords

ALLERGEN; ARACHIDONATE 5 LIPOXYGENASE; B7 ANTIGEN; C REACTIVE PROTEIN; CD11 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CYCLIC GMP; ELASTASE; GAMMA INTERFERON; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; LEUKOTRIENE B4; MACROLIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHODIESTERASE IV; ROFLUMILAST; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

AIRWAY SMOOTH MUSCLE CELL; APOPTOSIS; ASTHMA; BRONCHIAL THERMOPLASTY; CELL MIGRATION; CELL PROLIFERATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ENZYME INHIBITION; HUMAN; INFLAMMATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIC ASTHMA; NONHUMAN; PATHOPHYSIOLOGY; PAUCI IMMUNE ASTHMA; PRIORITY JOURNAL; RESPIRATORY CARE; RESPIRATORY TRACT ALLERGY; REVIEW; TH2 CELL; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

ASTHMA; DISEASE PROGRESSION; HUMANS; LEUKOCYTE COUNT; NEUTROPHILS; PHENOTYPE; SEVERITY OF ILLNESS INDEX;

EID: 84976532541     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2016.03.007     Document Type: Review

References (59)

1. 1 Knudsen, T.B., Thomsen, S.F., Nolte, H., et al. A population-based clinical study of allergic and non-allergic asthma. J Asthma 46:1 (2009), 91–94.
2. 2 Koziol-White, C.J., Panettieri, R.A. Jr., Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunol Rev 242 (2011), 178–185.
3. 3 Athens, J.W., Haab, O.P., Raab, S.O., et al. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 40 (1961), 989–995.
4. 4 Hetherington, S.V., Quie, P.G., Human polymorphonuclear leukocytes of the bone marrow, circulation, and marginated pool: function and granule protein content. Am J Hematol 20 (1985), 235–246.
5. 5 Damera, G., Panettieri, R.A. Jr., Does airway smooth muscle express an inflammatory phenotype in asthma?. Br J Pharmacol 163:1 (2011), 68–80.
6. 6 Damera, G., Panettieri, R.A., Irreversible airway obstruction in asthma: what we lose, we lose early. Allergy Asthma Proc 35:2 (2014), 111–118.
7. 7 Chung, K.F., Defining phenotypes in asthma: a step towards personalized medicine. Drugs 74:7 (2014), 719–728.
8. 8 Baines, K.J., Simpson, J.L., Wood, L.G., et al. Systemic upregulation of neutrophil alpha-defensins and serine proteases in neutrophilic asthma. Thorax 66:11 (2011), 942–947.
9. 9 Douwes, J., Gibson, P., Pekkanen, J., et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57:7 (2002), 643–648.
10. 10 Simpson, J.L., Baines, K.J., Ryan, N., et al. Neutrophilic asthma is characterised by increased rhinosinusitis with sleep disturbance and GERD. Asian Pac J Allergy Immunol 32:1 (2014), 66–74.
11. 11 Shaw, D.E., Berry, M.A., Hargadon, B., et al. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 132:6 (2007), 1871–1875.
12. 12 Louis, R., Lau, L.C., Bron, A.O., et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 161:1 (2000), 9–16.
13. 13 Teran, L.M., Campos, M.G., Begishvilli, B.T., et al. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy 27:4 (1997), 396–405.
14. 14 Uddin, M., Nong, G., Ward, J., et al. Prosurvival activity for airway neutrophils in severe asthma. Thorax 65:8 (2010), 684–689.
15. 15 Wenzel, S.E., Szefler, S.J., Leung, D.Y., et al. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156:3 Pt 1 (1997), 737–743.
16. 16 Bruijnzeel, P.L., Uddin, M., Koenderman, L., Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease-relevant neutrophil phenotype?. J Leukoc Biol 98:4 (2015), 549–556.
17. 17 Jatakanon, A., Uasuf, C., Maziak, W., et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160:5 Pt 1 (1999), 1532–1539.
18. 18 Simpson, J.L., Grissell, T.V., Douwes, J., et al. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62:3 (2007), 211–218.
19. 19 Uddin, M., Lau, L.C., Seumois, G., et al. EGF-induced bronchial epithelial cells drive neutrophil chemotactic and anti-apoptotic activity in asthma. PLoS One, 8(9), 2013, e72502.
20. 20 Wood, L.G., Baines, K.J., Fu, J., et al. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest 142:1 (2012), 86–93.
21. 21 Shi, J., Gilbert, G.E., Kokubo, Y., et al. Role of the liver in regulating numbers of circulating neutrophils. Blood 98:4 (2001), 1226–1230.
22. 22 Dancey, J.T., Deubelbeiss, K.A., Harker, L.A., et al. Neutrophil kinetics in man. J Clin Invest 58:3 (1976), 705–715.
23. 23 Pillay, J., Kamp, V.M., van Hoffen, E., et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 122:1 (2012), 327–336.
24. 24 Buckley, C.D., Ross, E.A., McGettrick, H.M., et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol 79:2 (2006), 303–311.
25. 25 Bullens, D.M., Truyen, E., Coteur, L., et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir Res, 7, 2006, 135.
26. 26 Woodfin, A., Voisin, M.B., Beyrau, M., et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 12:8 (2011), 761–769.
27. 27 Gounni, A.S., Lamkhioued, B., Koussih, L., et al. Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma. FASEB J 15:6 (2001), 940–949.
28. 28 Maletto, B.A., Ropolo, A.S., Alignani, D.O., et al. Presence of neutrophil-bearing antigen in lymphoid organs of immune mice. Blood 108:9 (2006), 3094–3102.
29. 29 Geng, S., Matsushima, H., Okamoto, T., et al. Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood 121:10 (2013), 1690–1700.
30. 30 Cosmi, L., Annunziato, F., Galli, M.I.G., et al. CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 30:10 (2000), 2972–2979.
31. 31 Matsushima, H., Geng, S., Lu, R., et al. Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood 121:10 (2013), 1677–1689.
32. 32 Mann, B.S., Chung, K.F., Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy. Respir Res, 7, 2006, 59.
33. 33 Banerjee, A., Damera, G., Bhandare, R., et al. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol 155:1 (2008), 84–92.
34. 34 Black, J.L., Panettieri, R.A. Jr., Banerjee, A., et al. Airway smooth muscle in asthma: just a target for bronchodilation?. Clin Chest Med 33:3 (2012), 543–558.
35. 35 Damera, G., Fogle, H.W., Lim, P., et al. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol 158 (2009), 1429–1441.
36. 36 Davies, D.E., Epithelial barrier function and immunity in asthma. Ann Am Thorac Soc 11:Suppl 5 (2014), S244–S251.
37. 37 Amrani, Y., Lazaar, A.L., Panettieri, R.A. Jr., Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kB-dependent signaling pathway that is only partially sensitive to dexamethasone. J Immunol 163 (1999), 2128–2134.
38. 38 Bhandare, R., Damera, G., Banerjee, A., et al. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am J Respir Cell Mol Biol 42:1 (2010), 9–15.
39. 39 Tliba, O., Panettieri, R.A. Jr., Tliba, S., et al. TNF-a differentially regulates the expression of pro-inflammatory genes in human airway smooth muscle cells by activation of IFN-b-dependent CD38 pathway. Mol Pharmacol 66 (2004), 322–329.
40. 40 Tliba, O., Tliba, S., Huang, C.D., et al. TNFalpha modulates airway smooth muscle function via the autocrine action of IFNbeta. J Biol Chem 278:50 (2003), 50615–50623.
41. 41 Ammit, A.J., Lazaar, A.L., Irani, C., et al. Tumor necrosis factor-a-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and b-agonists. Am J Respir Cell Mol Biol 26 (2002), 465–474.
42. 42 Barnes, P.J., Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J Allergy Clin Immunol 136:3 (2015), 531–545.
43. 43 Magnussen, H., Watz, H., Sauer, M., et al. Safety and efficacy of SCH527123, a novel CXCR2 antagonist, in patients with COPD. Eur Respir J, 36(Suppl), 2010, 38S.
44. 44 Nair, P., Gaga, M., Zervas, E., et al. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy 42:7 (2012), 1097–1103.
45. 45 Al-Ramli, W., Prefontaine, D., Chouiali, F., et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol 123:5 (2009), 1185–1187.
46. 46 Chesne, J., Braza, F., Mahay, G., et al. IL-17 in severe asthma. Where do we stand?. Am J Respir Crit Care Med 190:10 (2014), 1094–1101.
47. 47 Wenzel, S.E., Barnes, P.J., Bleecker, E.R., et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 179:7 (2009), 549–558.
48. 48 Calverley, P.M., Rabe, K.F., Goehring, U.M., et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374:9691 (2009), 685–694.
49. 49 Kraft, M., Cassell, G.H., Pak, J., et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121:6 (2002), 1782–1788.
50. 50 Sutherland, E.R., King, T.S., Icitovic, N., et al. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 126:4 (2010), 747–753.
51. 51 Hodge, S., Hodge, G., Brozyna, S., et al. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J 28:3 (2006), 486–495.
52. 52 Kobayashi, Y., Wada, H., Rossios, C., et al. A novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kappaB inhibition. J Pharmacol Exp Ther 345:1 (2013), 76–84.
53. 53 Brusselle, G.G., Vanderstichele, C., Jordens, P., et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 68:4 (2013), 322–329.
54. 54 Simpson, J.L., Powell, H., Boyle, M.J., et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177:2 (2008), 148–155.
55. 55 Castro, M., Rubin, A.S., Laviolette, M., et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 181:2 (2010), 116–124.
56. 56 Wechsler, M.E., Laviolette, M., Rubin, A.S., et al. Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 132:6 (2013), 1295–1302.
57. 57 Chakir, J., Haj-Salem, I., Gras, D., et al. Effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in asthma. Ann Am Thorac Soc 12 (2015), 1612–1618.
58. 58 Denner, D.R., Doeing, D.C., Hogarth, D.K., et al. Airway inflammation after bronchial thermoplasty for severe asthma. Ann Am Thorac Soc 12:9 (2015), 1302–1309.
59. 59 Panettieri, R.A. Jr., Bronchial thermoplasty: targeting structural cells in severe persistent asthma. Ann Am Thorac Soc 12:11 (2015), 1593–1594.